ACMSY实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (1 Jan 1970 @ 08:00):

Accustem Sciences Limited engages in the genomic signature-based assay business for the prognosis of early and late recurrence of ER+/HER2 breast cancer in early stage breast cancer patients...

Stats
今日成交量	1 220.00
平均成交量	18 163.00
市值	0.00
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0380 (28.15%)

Insider Trading

Date	Person	Action	Amount	type
2022-12-30	Cerrone Gabriele M	Buy	5 000	Common Stock
2022-12-02	Cerrone Gabriele M	Buy	3 729	Common Stock
2022-11-18	Cerrone Gabriele M	Buy	24 500	Common Stock
2021-12-01	Simon Willy Jules	Sell	0	Common Stock
2021-08-01	Simon Willy Jules	Sell	1 464	Option (right to buy)

INSIDER POWER
100.00
Last 13 transactions
Buy: 33 229 \| Sell: 601 665

AccuStem Sciences Limited 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

AccuStem Sciences Limited 财务报表

Annual	2022
营收:	$0
毛利润:	$0 (0.00 %)
EPS:	$-0.340

FY	2022
营收:	$0
毛利润:	$0 (0.00 %)
EPS:	$-0.340

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.0670

Financial Reports:

No articles found.

AccuStem Sciences Limited

Accustem Sciences Limited engages in the genomic signature-based assay business for the prognosis of early and late recurrence of ER+/HER2 breast cancer in early stage breast cancer patients. The company was incorporated in 2020 and is based in London, the United Kingdom.